• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型肿瘤内皮标志物 CLEC14A 的鉴定及其血管生成作用。

Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.

机构信息

Angiogenesis Group, Centre for Cardiovascular Sciences, Institute for Biomedical Research, Schools of Immunity and Infection and Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

出版信息

Oncogene. 2012 Jan 19;31(3):293-305. doi: 10.1038/onc.2011.233. Epub 2011 Jun 27.

DOI:10.1038/onc.2011.233
PMID:21706054
Abstract

Tumor endothelial markers (TEMs) that are highly expressed in human tumor vasculature compared with vasculature in normal tissue hold clear therapeutic potential. We report that the C-type lectin CLEC14A is a novel TEM. Immunohistochemical and immunofluorescence staining of tissue arrays has shown that CLEC14A is strongly expressed in tumor vasculature when compared with vessels in normal tissue. CLEC14A overexpression in tumor vessels was seen in a wide range of solid tumor types. Functional studies showed that CLEC14A induces filopodia and facilitates endothelial migration, tube formation and vascular development in zebrafish that is, CLEC14A regulates pro-angiogenic phenotypes. CLEC14A antisera inhibited cell migration and tube formation, suggesting that anti-CLEC14A antibodies may have anti-angiogenic activity. Finally, in endothelial cultures, expression of CLEC14A increased at low shear stress, and we hypothesize that low shear stress due to poor blood flow in the disorganized tumor vasculature induces expression of CLEC14A on tumor vessels and pro-angiogenic phenotypes.

摘要

肿瘤内皮标志物(TEMs)在人类肿瘤血管中表达水平高于正常组织中的血管,具有明确的治疗潜力。我们报告称,C 型凝集素 CLEC14A 是一种新型的 TEM。组织芯片的免疫组织化学和免疫荧光染色表明,与正常组织中的血管相比,CLEC14A 在肿瘤血管中强烈表达。在广泛的实体瘤类型中均观察到肿瘤血管中 CLEC14A 的过表达。功能研究表明,CLEC14A 诱导丝状伪足形成,并促进斑马鱼内皮细胞的迁移、管形成和血管发育,即 CLEC14A 调节促血管生成表型。CLEC14A 抗血清抑制细胞迁移和管形成,表明抗 CLEC14A 抗体可能具有抗血管生成活性。最后,在血管内皮细胞培养中,低切应力下 CLEC14A 的表达增加,我们假设紊乱的肿瘤血管中由于血流不良导致的低切应力诱导肿瘤血管上 CLEC14A 的表达和促血管生成表型。

相似文献

1
Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.新型肿瘤内皮标志物 CLEC14A 的鉴定及其血管生成作用。
Oncogene. 2012 Jan 19;31(3):293-305. doi: 10.1038/onc.2011.233. Epub 2011 Jun 27.
2
Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro.靶向肿瘤内皮细胞标志物 clec14a 的 C 型凝集素样结构域的人源抗体调节体外血管生成特性。
Oncogene. 2013 Nov 28;32(48):5449-57. doi: 10.1038/onc.2013.156. Epub 2013 May 6.
3
An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours.评估肿瘤内皮标志物 CLEC14A 作为实体瘤治疗靶点的研究。
J Pathol Clin Res. 2020 Oct;6(4):308-319. doi: 10.1002/cjp2.176. Epub 2020 Jul 21.
4
Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.通过靶向 CLEC14a 的优化抗体抑制 VEGF 依赖性血管生成和肿瘤血管生成。
Mol Oncol. 2018 Mar;12(3):356-372. doi: 10.1002/1878-0261.12169. Epub 2018 Jan 26.
5
Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.多聚蛋白-2是14族C型凝集素CLEC14A、CD93和CD248的配体,跨越内皮细胞与周细胞界面。
Oncogene. 2017 Nov 2;36(44):6097-6108. doi: 10.1038/onc.2017.214. Epub 2017 Jul 3.
6
Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance.新型内皮标志物C型凝集素14A在上皮性卵巢癌中的表达及其预后意义。
Int J Clin Oncol. 2017 Feb;22(1):107-117. doi: 10.1007/s10147-016-1033-6. Epub 2016 Aug 27.
7
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth.嵌合抗原受体 T 细胞靶向肿瘤内皮标志物 CLEC14A 抑制肿瘤生长。
JCI Insight. 2020 Oct 2;5(19):138808. doi: 10.1172/jci.insight.138808.
8
CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker.CLEC14A 在肝细胞癌中上调,可能作为一种潜在的诊断生物标志物。
Clinics (Sao Paulo). 2022 May 13;77:100029. doi: 10.1016/j.clinsp.2022.100029. eCollection 2022.
9
Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.碳水化合物结合蛋白CLEC14A在血管生成和淋巴管生成过程中调节依赖血管内皮生长因子受体2(VEGFR-2)和血管内皮生长因子受体3(VEGFR-3)的信号。
J Clin Invest. 2017 Feb 1;127(2):457-471. doi: 10.1172/JCI85145. Epub 2016 Dec 19.
10
Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2).发芽血管生成受类菱形蛋白2(RHBDL2)催化的C型凝集素家族14成员A(CLEC14A)胞外域脱落调控。
FASEB J. 2016 Jun;30(6):2311-23. doi: 10.1096/fj.201500122R. Epub 2016 Mar 3.

引用本文的文献

1
Tumor-associated macrophage-based predictive and prognostic model for hepatocellular carcinoma.基于肿瘤相关巨噬细胞的肝细胞癌预测和预后模型
PLoS One. 2025 Jul 2;20(7):e0325120. doi: 10.1371/journal.pone.0325120. eCollection 2025.
2
An organotypic atlas of human vascular cells.人类血管细胞的器官型图谱。
Nat Med. 2024 Dec;30(12):3468-3481. doi: 10.1038/s41591-024-03376-x. Epub 2024 Nov 20.
3
Type-H endothelial cell protein Clec14a orchestrates osteoblast activity during trabecular bone formation and patterning.Type-H 内皮细胞蛋白 Clec14a 在小梁骨形成和模式形成过程中协调成骨细胞的活性。
Commun Biol. 2024 Oct 11;7(1):1296. doi: 10.1038/s42003-024-06971-3.
4
Group XIV C-type lectins: emerging targets in tumor angiogenesis.第十四组 C 型凝集素:肿瘤血管生成中的新兴靶点。
Angiogenesis. 2024 May;27(2):173-192. doi: 10.1007/s10456-024-09907-x. Epub 2024 Mar 12.
5
A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers.一种用于泛癌免疫治疗和预后的肿瘤相关内皮特征评分模型。
Front Pharmacol. 2023 Aug 31;14:1190660. doi: 10.3389/fphar.2023.1190660. eCollection 2023.
6
Benzo[a]pyrene Exposure Reduces Cell-Type Diversity and Stimulates Sex-Biased Damage Pathways in End Organs of Lupus-Prone Mice.苯并[a]芘暴露降低狼疮易感小鼠终末器官的细胞类型多样性,并刺激性别偏向的损伤途径。
Int J Mol Sci. 2023 Mar 24;24(7):6163. doi: 10.3390/ijms24076163.
7
DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer.DNA甲基化与三阴性和腔面B型乳腺癌新辅助化疗疗效预测的前景
Cancers (Basel). 2023 Mar 6;15(5):1630. doi: 10.3390/cancers15051630.
8
Tumor buster - where will the CAR-T cell therapy 'missile' go?肿瘤克星——CAR-T 细胞疗法的“导弹”将飞向何方?
Mol Cancer. 2022 Oct 19;21(1):201. doi: 10.1186/s12943-022-01669-8.
9
Pharmacokinetic evaluation of radiolabeled intraocular anti-CLEC14a antibody in preclinical animal species and application in humans.放射性标记的眼内抗 CLEC14a 抗体在临床前动物物种中的药代动力学评估及其在人类中的应用。
Clin Transl Sci. 2022 Dec;15(12):2938-2946. doi: 10.1111/cts.13412. Epub 2022 Sep 27.
10
Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology.共同靶向肿瘤血管生成与免疫抑制性肿瘤微环境:民族药理学视角
Front Pharmacol. 2022 Jun 15;13:886198. doi: 10.3389/fphar.2022.886198. eCollection 2022.